title: Not just chlorthalidone: evidence-based, single tablet, diuretic alternatives to hydrochlorothiazide for hypertension.
abstract: Accounting for 15 % of deaths worldwide, hypertension is often treated with hydrochlorothiazide (HCTZ) (50 million prescriptions annually). HCTZ has a <24-h duration of action, is less potent than chlorthalidone and all major antihypertensive drug classes, and is inferior to four antihypertensive drugs for cardiovascular event (CVE) reduction. If there were alternative diuretics, why prescribe HCTZ? Chlorthalidone is often offered as an alternative to HCTZ, but has limited pharmaceutical formulations. However, there are seven evidence-based, single-tablet, alternative diuretics. For reducing CVE, the following are superior to their comparators: chlorthalidone versus four antihypertensives in multiple hypertensive populations; indapamide versus placebo in elderly Chinese (and versus enalapril for left ventricular hypertrophy), triamterene-HCTZ versus placebo in elderly Europeans, amiloride-HCTZ versus three antihypertensives, and indapamide-perindopril versus placebo in three populations. Additionally, chlorthalidone-azilsartan and spironolactone-HCTZ are potent combinations The aldosterone antagonist component of the latter combination has been shown to reduce total mortality by 30 % in heart failure. Five of these seven have multiple dose formulations. Six cost $4-$77 monthly. In conclusion, based on both scientific and practical grounds, new prescriptions for HCTZ are rarely justified.
authors.affiliation: UCONN School of Medicine and St. Vincent's Medical Center, 2800 Main Street, Bridgeport, CT, 06606, USA, groush@gcr0.com.
authors.forename: George C
authors.initials: GC
authors.lastname: Roush
authors.forename: Michael E
authors.initials: ME
authors.lastname: Ernst
authors.forename: John B
authors.initials: JB
authors.lastname: Kostis
authors.forename: Ramandeep
authors.initials: R
authors.lastname: Kaur
authors.forename: Domenic A
authors.initials: DA
authors.lastname: Sica
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002752:Chlorthalidone / Q000191:economics / Q000627:therapeutic use*; D055317:Evidence-Based Practice; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy; D013607:Tablets
chemical_list: D013607:Tablets; D002752:Chlorthalidone
references.citation: Int J Clin Pharmacol Ther Toxicol. 1992 Jan;30(1):34-7
references.pmid: 1551742
references.citation: Hypertension. 2010 Sep;56(3):463-70
references.pmid: 20625077
references.citation: Am J Cardiol. 1987 Oct 1;60(10):820-5
references.pmid: 3661395
references.citation: J Clin Hypertens (Greenwich). 2014 Aug;16(8):561-8
references.pmid: 25039609
references.citation: N Engl J Med. 1994 Jun 30;330(26):1852-7
references.pmid: 8196728
references.citation: J Am Soc Hypertens. 2010 Nov-Dec;4(6):290-4
references.pmid: 21130975
references.citation: JAMA. 1991 Jun 26;265(24):3255-64
references.pmid: 2046107
references.citation: Am J Cardiol. 1996 Feb 22;77(6):17b-19b
references.pmid: 8848988
references.citation: Cochrane Database Syst Rev. 2009 Jul 08;(3):CD001841
references.pmid: 19588327
references.citation: Hypertension. 2004 Jan;43(1):4-9
references.pmid: 14638621
references.citation: Hypertension. 2011 Dec;58(6):994-5
references.pmid: 22025371
references.citation: Curr Med Res Opin. 2011 Mar;27(3):497-502
references.pmid: 21208153
references.citation: J Cardiovasc Pharmacol. 1996 Mar;27(3):424-7
references.pmid: 8907805
references.citation: Hypertension. 2015 May;65(5):1041-6
references.pmid: 25733245
references.citation: J Am Coll Cardiol. 2011 Feb 1;57(5):590-600
references.pmid: 21272751
references.citation: J Clin Hypertens (Greenwich). 2009 Jan;11(1):5-10
references.pmid: 19125852
references.citation: Expert Opin Pharmacother. 2009 Jul;10(10):1529-36
references.pmid: 19514864
references.citation: Am J Hypertens. 2010 Apr;23(4):440-6
references.pmid: 20111008
references.citation: Clin Pharmacokinet. 1999;37 Suppl 1:7-12
references.pmid: 10491728
references.citation: N Engl J Med. 2009 Nov 26;361(22):2153-64
references.pmid: 19940300
references.citation: Hypertension. 2008 Jan;51(1):69-76
references.pmid: 17968001
references.citation: Am J Hypertens. 2003 Nov;16(11 Pt 1):925-30
references.pmid: 14573330
references.citation: J Clin Hypertens (Greenwich). 2011 Jul;13(7):467-72
references.pmid: 21762358
references.citation: Pharmacotherapy. 1993 Sep-Oct;13(5):487-93
references.pmid: 8247917
references.citation: JAMA. 2002 Dec 18;288(23):2981-97
references.pmid: 12479763
references.citation: Am J Cardiol. 1996 Feb 22;77(6):26B-30B
references.pmid: 8848991
references.citation: Chronobiol Int. 2010 Sep;27(8):1629-51
references.pmid: 20854139
references.citation: Clin Ther. 2004 Feb;26(2):257-70
references.pmid: 15038948
references.citation: Am J Cardiol. 1993 Jan 21;71(3):40A-45A
references.pmid: 8422004
references.citation: Drugs. 2006;66(2):257-71
references.pmid: 16451099
references.citation: Hypertension. 2010 Sep;56(3):335-7
references.pmid: 20625074
references.citation: Hypertension. 2012 Jun;59(6):1110-7
references.pmid: 22526259
references.citation: Mol Cell Biochem. 1998 Jan;178(1-2):151-5
references.pmid: 9546594
references.citation: Arch Intern Med. 1981 Mar;141(4):482-6
references.pmid: 7011237
references.citation: J Hypertens. 2004 Nov;22(11):2217-26
references.pmid: 15480108
references.citation: N Engl J Med. 2003 Feb 13;348(7):583-92
references.pmid: 12584366
references.citation: Lancet. 2007 Sep 8;370(9590):829-40
references.pmid: 17765963
references.citation: Hypertension. 2011 Mar;57(3):413-20
references.pmid: 21282560
references.citation: Hypertension. 2003 Sep;42(3):239-46
references.pmid: 12925554
references.citation: BMJ. 1992 Feb 15;304(6824):405-12
references.pmid: 1445513
references.citation: Hypertension. 2012 Jun;59(6):1104-9
references.pmid: 22547443
references.citation: Am J Med. 2012 Dec;125(12):1229.e1-1229.e10
references.pmid: 22939358
references.citation: Hypertens Res. 2013 Jan;36(1):79-84
references.pmid: 23034468
references.citation: Cochrane Database Syst Rev. 2010 Aug 04;(8):CD008169
references.pmid: 20687095
references.citation: Circulation. 2008 Jun 24;117(25):e510-26
references.pmid: 18574054
references.citation: J Cardiovasc Pharmacol. 1993;22 Suppl 6:S57-63
references.pmid: 7508063
references.citation: Eur J Clin Pharmacol. 1988;33(6):577-9
references.pmid: 3366161
references.citation: Lancet. 1985 Jun 15;1(8442):1349-54
references.pmid: 2861311
references.citation: N Engl J Med. 1999 Sep 2;341(10):709-17
references.pmid: 10471456
references.citation: Hypertension. 2011 Dec;58(6):1001-7
references.pmid: 22025372
references.citation: Hypertension. 2002 Oct;40(4):504-10
references.pmid: 12364354
references.citation: N Engl J Med. 2008 May 1;358(18):1887-98
references.pmid: 18378519
references.citation: Am J Cardiol. 1990 May 2;65(17):77H-80H
references.pmid: 2184657
references.citation: Am J Cardiol. 1990 May 2;65(17):11H-27H
references.pmid: 2184650
references.citation: Am Fam Physician. 2008 Aug 15;78(4):444, 446
references.pmid: 18756650
references.citation: J Hypertens. 2013 Jul;31(7):1281-357
references.pmid: 23817082
references.citation: Clin Pharmacol Ther. 1984 Oct;36(4):431-5
references.pmid: 6478730
references.citation: Lancet. 2000 Jul 29;356(9227):366-72
references.pmid: 10972368
references.citation: Hypertension. 2006 Mar;47(3):352-8
references.pmid: 16432050
references.citation: Am J Hypertens. 2004 Aug;17 (8):660-7
references.pmid: 15323062
references.citation: JAMA. 2014 Feb 5;311(5):507-20
references.pmid: 24352797
references.citation: Curr Hypertens Rep. 2008 Aug;10(4):293-7
references.pmid: 18625158
references.citation: Hypertension. 2011 Apr;57(4):689-94
references.pmid: 21383313
references.citation: J Clin Hypertens (Greenwich). 2011 Sep;13(9):644-8
references.pmid: 21896143
references.citation: Am J Hypertens. 2004 Mar;17(3):245-51
references.pmid: 15001199
references.citation: Blood Press. 2003;12(3):160-7
references.pmid: 12875478
references.citation: J Clin Hypertens (Greenwich). 2014 Jan;16(1):14-26
references.pmid: 24341872
references.citation: Lancet. 2001 Sep 29;358(9287):1033-41
references.pmid: 11589932
references.citation: Hypertension. 2005 Sep;46(3):481-7
references.pmid: 16116042
references.citation: Hypertension. 2003 May;41(5):1063-71
references.pmid: 12654706
references.citation: Ann Intern Med. 2013 Mar 19;158(6):447-55
references.pmid: 23552325
references.citation: Am J Med. 1986 Feb 14;80(2A):3-6
references.pmid: 2868657
references.citation: Hypertension. 2012 May;59(5):934-42
references.pmid: 22493073
references.citation: J Hypertens. 2014 Dec;32(12):2332-40; discussion 2340
references.pmid: 25333682
references.citation: J Hypertens. 2004 Aug;22(8):1613-22
references.pmid: 15257186
references.citation: N Engl J Med. 2013 Sep 5;369(10):954-64
references.pmid: 24004122
references.citation: JAMA. 2003 May 21;289(19):2534-44
references.pmid: 12759325
references.citation: J Cardiovasc Pharmacol. 1993;22 Suppl 6:S106-10
references.pmid: 7508055
references.citation: Cochrane Database Syst Rev. 2012 Nov 14;11:CD008167
references.pmid: 23152254
references.citation: Chin Med J (Engl). 1995 Sep;108(9):710-7
references.pmid: 8575241
references.citation: J Hypertens. 2005 Nov;23 (11):2063-70
references.pmid: 16208150
references.citation: Hypertension. 2010 Feb;55(2):399-407
references.pmid: 20026768
references.citation: J Hypertens. 2000 Oct;18(10):1465-75
references.pmid: 11057435
references.citation: Clin Pharmacol Ther. 1985 Jan;37(1):61-5
references.pmid: 3880686
references.citation: Am J Hypertens. 1995 Dec;8(12 Pt 1):1154-9
references.pmid: 8998248
references.citation: JAMA. 2014 Nov 19;312(19):2030-1
references.pmid: 25399279
references.citation: Hypertension. 2007 Apr;49(4):839-45
references.pmid: 17309946
references.citation: N Engl J Med. 2008 Dec 4;359(23):2417-28
references.pmid: 19052124